Portopulmonary hypertension and the liver transplant candidate

Transplantation

Volumn 67, Issue 8, 1999, Pages 1087-1093

  Kuo, Paul C ^a   Plotkin, Jeffrey S ^b   Gaine, Sean ^c   Schroeder, Rebecca A ^b   Rustgi, Vinod K ^a   Rubin, Lewis J ^c   Johnson, Lynt B ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; NIFEDIPINE; NITRIC OXIDE; PROSTACYCLIN DERIVATIVE; VASODILATOR AGENT;

ARTICLE; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; HEART PRELOAD; HEART RIGHT VENTRICLE FUNCTION; INFUSION PUMP; INHALATIONAL DRUG ADMINISTRATION; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PORTAL HYPERTENSION; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT CONTRAINDICATION;

HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER DISEASES; LIVER TRANSPLANTATION; POSTOPERATIVE PERIOD;

EID: 0033609066     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199904270-00001     Document Type: Article

References (41)

1. Taura P, Garcia-Valdecasas JC, Beltran J, et al. Moderate primary pulmonary hypertension in patients undergoing liver transplantation. Anesth Analg 1996; 83: 675.
2. Plevak D, Krowka M, Rettke S, Dunn W, Southern P. Successful liver transplantation in patients with mild to moderate pulmonary hypertension. Transplant Proc 1993; 25: 1840.
3. Castro M, Krowka MJ, Schroeder DR, et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc 1996; 71: 543.
4. Plotkin JS, Kuo PC, Rubin LJ, et al. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation 1998; 65: 457.
5. Mandall MS, Krowka MJ. Formation of a national database on pulmonary hypertension and hepatopulmonary syndrome in chronic liver disease. Anesthesiology 1997; 87: 450.
6. Rubin LJ. Primary pulmonary hypertension. Chest 1993; 104: 236.
7. Kuo PC, Plotkin JS, Johnson LB, et al. Distinctive clinical features of portopulmonary hypertension [see Comments]. Chest 1997; 112: 980.
8. Ramsay MAE, Schmidt A, Hein HA, et al. Nitric oxide does not reverse pulmonary hypertension associated with end-stage liver disease: a preliminary report. Hepatology 1997; 25: 524.
9. Ramsay MA, Simpson Br, Nguyen AT, Ramsay KJ, East C, Klintmalm GB. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 1997; 3: 494.
10. Jones FD, Kuo PC, Johnson LB, Njoku MJ, Dixon-Ferguson MK, Plotkin JS. The co-existence of portopulmonary hypertension and hepatopulmonary syndrome. Anesthesiology (in press).
11. McDonnell PJ, Toye PA, Hutchins GM. Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis 1983; 127: 437.
12. Hadengue A, Benhayoun K, Lebrec D. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991; 100: 520.
13. Schraufnagel DE, Kay JM. Structural and pathologic changes in lung vasculature in chronic liver disease. Clin Chest Med 1996; 17: 1.
14. Krowka MJ. Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas. Hepatology 1997; 25: 1282.
15. Matsubara O, Nakamura T, Uehara T, Kasuga T. Histometrical investigations of the pulmonary artery in severe hepatic disease. J Pathol 1984; 143: 31.
16. Robalino BD, Moodie DS. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol 1991; 17: 492.
17. De Wolf Am, Scott VL, Gasior T, Kang Y. Pulmonary hypertension and liver transplantation. Anesthesiology 1993; 78: 213.
18. Galie N, Ussia G, Passarelli P, Parlangeli R, Branzi A, Magnani B. Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol 1995; 75: 55A.
19. Kuo PC, Schroeder RA, Vagelos RH, et al. Volume-mediated pulmonary responses in liver transplant candidates. Clin Transplant 1996; 10: 521.
20. Pepke Z, Higenbottam T, Dinh-Xuan A, Stone D, Wan Y. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173.
21. Rich S, Kaufmann E, Levy PS. The effects of high doses of calcium channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327: 76.
22. Rich S, Brundage BH. High dose calcium channel blocking therapy for primary pulmonary hypertension: evidence for long term reduction in pulmonary artery pressure and regression of right ventricular hypertrophy. Circulation 1987; 76: 135.
23. Channick RN, Newhart JW, Johnson FW. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. Chest 1996; 109: 1545.
24. Mandell MS, Duke J. Nitric oxide reduces pulmonary hypertension during hepatic transplantation. Anesthesiology 1994; 81: 1538.
25. Paker M, Medina N, Yushak M. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease. J Am Coll Cardiol 1984; 4: 890.
26. Weir E, Rubin L, Ayres S. The acute administration of vasodilators in primary pulmonary hypertension: experience from the National Institutes of Health registry on primary pulmonary hypertension. Am Rev Respir Dis 1989; 140: 1623.
27. Rubin L, Mendoza J, Hood M. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin. results of a randomized trial. Ann Intern Med 1990; 112: 485.
28. Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS. Survival in primary pulmonary hypertension with long-term intravenous prostacyclin. Ann Intern Med 1994; 121: 409.
29. Barst RJ, Rubin LJ, Long WA. A comparison of continuous intravenous epoprostenol with conventional therapy for primary pulmonary hypertension. N Engl J Med 1998; 334: 296.
30. Kuo PC, Johnson LB, Plotkin JS, Howell CD, Bartlett ST, Rubin LJ. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 1997; 63: 604.
31. McLaughlin V, Genthner D, Panella M, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol therapy in primary pulmonary hypertension. N Engl J Med 1998; 338: 273.
32. Fishman A. Pulmonary hypertension-beyond vasodilator therapy. N Engl J Med 1998; 338: 321.
33. De Wolf Am, Scott V, Bjerke R, et al. Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension. Liver Trans Surg 1997; 3: 594.
34. Gillies BS, Perkins JD, Cheney FW. Abdominal aortic compression to treat circulatory collapse caused by severe pulmonary hypertension during liver transplantation. Anesthesiology 1996; 85: 40.
35. Cheng EY, Woehlck HJ. Pulmonary artery hypertension complicating anesthesia for liver transplantation. Anesthesiology 1992; 77: 389.
36. Yoshida EM, Erb SR, Pflugfelder PW, et al. Single-lung versus liver transplantation for the treatment of portopulmonary hypertension. Transplantation 1993; 55: 688.
37. Csete M. Intraoperative management of liver transplant patients with pulmonary hypertension. Liver Transpl Surg 1997; 3: 454.
38. Koneru B, Ahmed S, Weisse AB, Grant GP, McKim KA. Resolution of pulmonary hypertension of cirrhosis after liver transplantation. Transplantation 1994; 58: 1133.
39. Levy MT, Torzillo P, Bookallil M, Sheil AG, McCaughan GW. Delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosis. J Gastroenterol Hepatol 1996; 11: 734.
40. Losay J, Piot D, Bougaran J, et al. Early liver transplantation is crucial in children with liver disease and pulmonary artery hypertension. J Hepatol 1998; 28: 337.
41. Prager MC, Cauldwell CA, Ascher NL, Roberts JP, Wolfe CL. Pulmonary hypertension associated with liver disease is not reversible after liver transplantation. Anesthesiology 1992; 77: 375.